Previous studies have also reported high expression of SOX9, FOS, STAT1, and TIMP1 in GC tissues.[24, 25, 26, 27] Kaplan–Meier survival analysis further demonstrated that elevated expression of SOX9 and TIMP1 predicted poor prognosis, while higher STAT1 expression was associated with better outcomes (Figure S3C, Supporting Information). This evidence concerns the gene SOX9 and gastric cancer.